We are proud to establish the Miranda Filmer Fund in honour of Miranda, a gifted equestrienne and sportswoman, who had embarked on a promising career in magazine publishing. Miranda was diagnosed with neuroendocrine cancer in 2017 and died on 10 June 2022, aged  30. 

Miranda's oncologist Dr Dan Krell's words remind us of her courage: "Miranda was an inspirational patient, who continued to live life to its fullest right up until the very end. She exceeded all expectations for people diagnosed with aggressive neuroendocrine tumours, and can offer hope to future generations of patients".

The research funded in Miranda’s memory will raise crucial awareness of the disease and seek to open up new treatment possibilities for those living with the most aggressive forms of tumour.

The zebra motif is the universal symbol for international rare diseases such as neuroendocrine cancer and for us it is also a reference to Miranda's passion for horses. Clinicians are often urged to assume that the simplest explanation of a patient’s symptoms is correct. However medical “zebras” do exist, and it is important that clinicians are alert and equipped to diagnose and treat them early: “when you hear the sound of hoof beats, sometimes it is a zebra.”

Funds raised will support cutting-edge research at the Royal Free London NHS Foundation Trust – home to the world-renowned Neuroendocrine Tumour (NET) Research Unit. The work will be overseen by global NETs expert and centre director, Professor Martyn Caplin.

“We are so proud of our amazing and courageous daughter, and she will be forever remembered. The idea behind this research is to identify neuroendocrine tumours and neoplasms sooner and to target effective therapies and prolong the life of those diagnosed with this complex disease.” – Antonia and Charles Filmer.

To read more about Miranda a please visit www.MirandaFilmer.com 

To read more about the research, please visit: 
www.royalfreecharity.org/filmer-fund-study